Xsolla Expands Its Commitment to LATAM Game Development With the Journey of Indies (JOIN) Program
25.3.2025 15:00:00 EET | Business Wire | Press release
Xsolla, a leading global video game commerce company, is proud to announce the launch of the Journey of Indies (JOIN) Program, powered by Xsolla. This LATAM-focused initiative is designed to help indie and mid-tier game developers scale their businesses with commercialization tools, mentorship, and industry partnerships. By integrating developers into Xsolla's ecosystem of commercialization tools, this program aims to drive innovation, expand opportunities, and generate new revenue streams.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250325229062/en/
Graphic: Xsolla
Key Dates:
- March 25: Livestream announcing the JOIN Program at 5 PM ET.
- April 7: Accelerator begins to go live.
- April 25: Official hub opening in the city of Brasilia.
- April 30: Gamescom LATAM panel on the accelerator program in Brazil.
- June 22-26: B2B Innova Summit event in Brasilia.
In collaboration with Institutio Conecta and Indie Hero, the initiative will leverage a grant provided by the Secretariat of Science, Technology, and Innovation of the Federal District (SECTI-DF) to establish a video game hub in Brasilia. This hub will provide a dedicated space for education, business development, and hands-on commercialization training. The JOIN Program aligns with game developers’ associations, industry stakeholders, and public/private entities to unlock the region’s creative potential.
The Journey of Indies (JOIN) Program powered by Xsolla, is designed to address the unique challenges faced by indie and mid-tier developers in LATAM, offering structured support through:
- Exclusive One-Year Access to Educational Programs— Indie Hero will distribute JOIN’s educational content across Brazil, ensuring developers gain valuable insights into game business strategies.
- Mentorship & Talent Selection— JOIN will support selecting top candidates for various acceleration paths, helping developers refine their projects and business models.
- Hands-On Commercialization Training— Participants will gain a general knowledge of monetization and distribution, extending beyond just Xsolla’s tools. They will also learn to integrate Xsolla’s solutions into their go-to-market strategies.
- Industry-Wide Collaboration— Through Indie Hero’s extensive network of game associations and guilds across Brazil, the program will expand its reach and impact.
- Publishing & Distribution Support— Indie Hero’s publishing label, GoGo Games Interactive, will assist developers in seamlessly onboarding to Xsolla’s ecosystem.
“LATAM is one of the most promising and rapidly growing regions for game development,” said Chris Hewish, Chief Strategy Officer at Xsolla. “By partnering with key industry players and investing in local talent, we’re committed to providing the necessary resources and knowledge to help developers turn their creative visions into successful businesses.”
The Journey of Indies (JOIN) Program is now open for applications. Indie and mid-tier studios across LATAM are encouraged to apply and take advantage of this unparalleled opportunity to scale their businesses with Xsolla’s expertise.
For more information and to apply, visit: https://xsolla.pro/p6i
About Xsolla
Xsolla is a leading global video game commerce company with a robust and powerful set of tools and services designed specifically for the industry. Since its founding in 2005, Xsolla has helped thousands of game developers and publishers of all sizes fund, market, launch, and monetize their games globally and across multiple platforms. As an innovative leader in game commerce, Xsolla’s mission is to solve the inherent complexities of global distribution, marketing, and monetization to help our partners reach more geographies, generate more revenue, and create relationships with gamers worldwide. Headquartered and incorporated in Los Angeles, California, with offices in London, Berlin, Seoul, Beijing, Kuala Lumpur, Raleigh, Tokyo, Montreal, and cities around the world.
For more information, visit xsolla.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250325229062/en/
Contacts
Media Contact
Derrick Stembridge
Vice President of Global Public Relations, Xsolla
d.stembridge@xsolla.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alipay Launches Next-Generation AI Payment Infrastructure, Debuts AI Wallet and Token Pay to Power Agentic Economy26.5.2026 18:20:00 EEST | Press release
Alipay today introduced its full-stack AI payment solution to partners across industries, ranging from AI companies to traditional retailers, and debuted two new services — the world’s first AI Wallet and Token Pay — to support the agentic economy’s rapid growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526337824/en/ Alipay Unveils Next-generation AI Payment Infrastructure This launch extends Alipay's next-generation AI payment infrastructure, building on its consumer-facing product Alipay AI Pay and its business-facing AI payment processing product. “While the essence of commerce remains unchanged in the age of AI, the emergence of AI agents is reshaping everything. Drawing on 22 years of technological expertise and commercial know-how, Alipay is building a new generation of AI payment services to accelerate the growth of the agentic commerce ecosystem,” said Cyril Han, CEO of Ant Group. AI Wallet: Giving Users Vis
Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 202626.5.2026 18:00:00 EEST | Press release
Daiichi Sankyo Europe (DSE) is pleased to announce its extensive scientific presence at the European Atherosclerosis Society (EAS) Congress 2026. The presentation of 15 abstracts, comprising both clinical trial analyses and real-world evidence, underscores the company's sustained investment in cardiovascular health and its mission to care for every heartbeat. The 15-abstract showcase provides a comprehensive look at the role of bempedoic acid in lipid management. This includes post-hoc analyses in collaboration with Esperion Therapeutics from the Phase 3 CLEAR Outcomes trial exploring its impact on stroke and venous thromboembolism (VTE) incidence.5,6 There are also real-world findings from the MILOS registry, including a dedicated sub-analysis investigating the effectiveness of bempedoic acid across various background therapies.1,2,3,4 Results reinforce consistent effectiveness and safety profile of bempedoic acid across various EU countries and regardless of patients’ existing treatm
OpenRouter Raises $113 Million CapitalG-led Series B as Weekly Volume Explodes to 25T Tokens26.5.2026 16:15:00 EEST | Press release
OpenRouter, the AI model exchange, today announced a $113 million Series B led by Alphabet’s independent growth fund, CapitalG, with participation from investors including NVentures (NVIDIA’s venture capital arm), ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures, alongside existing investors including Andreessen Horowitz and Menlo Ventures. OpenRouter’s volume has surged to 25 trillion tokens per week (100 trillion tokens per month), representing a 5X increase from the 5 trillion tokens processed per week just six months ago. The explosion in token demand illustrates how quickly enterprises are deploying agents and scaling AI across multiple models and providers. OpenRouter’s infrastructure manages and optimizes inference and provides access to 400+ models across leading AI providers, including Anthropic, Google, OpenAI, xAI, and DeepSeek, among others. The platform is used by over 8 million global users, including AI-native startups and large enterprises,
Xsolla Expands Its Community Management Tools for Creators, Community Leaders, and Resellers26.5.2026 16:00:00 EEST | Press release
Xsolla, a leading global video game commerce company, today announced three simultaneous expansions of its community management tools and products. As the creator economy continues to reshape how games are discovered and the industry accelerates its shift toward direct-to-consumer commerce, Xsolla is building on its community management tools for creators, community leaders, and emerging markets, and will showcase them at TwitchCon Rotterdam later this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526596720/en/ Graphic: Xsolla The games industry has never had a shortage of people who drive player acquisition, loyalty, and commerce; it's had a shortage of infrastructure that recognizes them. Creators stream it. Community leaders build a culture around it. Local resellers get it into the hands of players in markets traditional channels can't reach. Each operates at the center of how games are discovered, adopted, an
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 15:00:00 EEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom